4.7 Article

Proteomic Analysis of Mucosal and Systemic Responses to SARS-CoV-2 Antigen

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Immunology

Longitudinal Systemic and Mucosal Immune Responses to SARS-CoV-2 Infection

Peter F. Wright et al.

Summary: Respiratory/mucosal and serum/systemic antibody responses to SARS-CoV-2 infection are distinct host defense mechanisms influenced by age, severity of illness, and immunoglobulin class. Stimulation of respiratory immunity is crucial for SARS-CoV-2 vaccines aiming to limit transmission.

JOURNAL OF INFECTIOUS DISEASES (2022)

Article Medicine, General & Internal

Mucosal immune response in BNT162b2 COVID-19 vaccine recipients

Lorenzo Azzi et al.

Summary: BNT162b2 COVID-19 vaccine induces strong systemic immune response but poorly activates mucosal immunity.

EBIOMEDICINE (2022)

Review Immunology

The Effect of Smoking on Humoral Response to COVID-19 Vaccines: A Systematic Review of Epidemiological Studies

Pietro Ferrara et al.

Summary: This rapid systematic review investigates the impact of smoking on humoral response to COVID-19 vaccines. The findings suggest that smokers have lower antibody titres or a more rapid decline in vaccine-induced antibodies compared to non-smokers. These results indicate a negative effect of smoking on the humoral response to COVID-19 vaccines.

VACCINES (2022)

Article Chemistry, Analytical

Matrix-Assisted Laser Desorption and Ionization Time-of-Flight Mass Spectrometry Analysis for the Direct Detection of SARS-CoV-2 in Nasopharyngeal Swabs

Tomoya Yoshinari et al.

Summary: Researchers have developed a method based on MALDI-ToF MS for the direct detection of SARS-CoV-2-specific peptides in nasopharyngeal swabs. This method involves simple purification steps and rapid detection, making it a reliable high-throughput diagnostic method for COVID-19.

ANALYTICAL CHEMISTRY (2022)

Article Virology

Distinct immune responses in the early phase to natural SARS-CoV-2 infection or vaccination

Pai Peng et al.

Summary: Immune responses to inactivated SARS-CoV-2 vaccines in the early phase show lower antibody levels compared to acute phase of natural infection, especially in IgA antibodies. Differences in antibody responses and cytokine levels between natural infection and vaccination with inactivated vaccines may provide insights for vaccine optimization and serological testing.

JOURNAL OF MEDICAL VIROLOGY (2022)

Article Immunology

Systemic and Mucosal Humoral Immune Response Induced by Three Doses of the BNT162b2 SARS-CoV-2 mRNA Vaccines

Roberta Mancuso et al.

Summary: This study monitored the long-term humoral responses of healthcare workers who received three doses of the BNT162b2 vaccine. The results showed that two doses of the vaccine induced strong immune responses, although these responses weakened over time. Individuals who had recovered from COVID-19 had more prolonged immune responses. The third vaccine dose quickly boosted humoral immune responses.

VACCINES (2022)

Review Immunology

The central role of the nasal microenvironment in the transmission, modulation, and clinical progression of SARS-CoV-2 infection

Oreste Gallo et al.

Summary: This study critically reviews the latest molecular and cellular findings on the mucosal response to SARS-CoV-2 in the nasal cavity and in NALT, and analyzes its impact on the subsequent course of COVID-19. The possibility of modulating the systemic inflammatory network against the virus starting from the initial phases of the nasal and nasopharyngeal response is explored, with potential clinical and epidemiological implications for mucosal vaccine development.

MUCOSAL IMMUNOLOGY (2021)

Article Immunology

Longitudinal Analysis of Inflammatory Response to SARS-CoV-2 in the Upper Respiratory Tract Reveals an Association with Viral Load, Independent of Symptoms

Diem-Lan Vu et al.

Summary: The study found that levels of certain cytokines in the nasal cavity of SARS-CoV-2-infected patients can remain elevated for up to 3 weeks, and some patients had S1-specific IgA present in their nasal cavity. In this mild cohort, anosmia was not associated with locally produced cytokines.

JOURNAL OF CLINICAL IMMUNOLOGY (2021)

Article Immunology

In Nasal Mucosal Secretions, Distinct IFN and IgA Responses Are Found in Severe and Mild SARS-CoV-2 Infection

Juliana de Melo Batista dos Santos et al.

Summary: The study found higher levels of specific-SIgA for SARS-CoV-2 and cytokines (IFN-beta and IFN-gamma) in the airways mucosa of COVID-19 patients. IL-12p70 levels were observed to be increased in the group with other viruses, and significant differences were found in the immune responses of airway mucosa among different groups of patients with or without SARS-CoV-2 infection.

FRONTIERS IN IMMUNOLOGY (2021)

Article Immunology

Distinct Features and Functions of Systemic and Mucosal Humoral Immunity Among SARS-CoV-2 Convalescent Individuals

Savannah E. Butler et al.

Summary: Understanding humoral immune responses to SARS-CoV-2 infection is crucial for vaccine development and antibody-based interventions. Antibody responses in convalescent individuals varied depending on disease severity, with systemic and mucosal responses showing different characteristics. Neutralization and antibody-mediated effector functions in serum correlated with IgG response magnitude, while nasal neutralization was associated with IgA response, highlighting the importance of assessing mucosal immunity in larger natural infection cohorts.

FRONTIERS IN IMMUNOLOGY (2021)

Article Immunology

Early Colorectal Responses to HIV-1 and Modulation by Antiretroviral Drugs

Carolina Herrera et al.

Summary: In the first 24 hours following exposure to HIV in colorectal tissue, inflammatory responses and a Th1 cytokine profile are induced, with the X4-tropic isolate showing greater changes at the proteomic and transcriptomic levels than the R5-tropic isolate.

VACCINES (2021)

Review Medicine, General & Internal

SARS-CoV-2 vaccines: Lights and shadows

Fabio Angeli et al.

Summary: SARS-CoV-2 vaccines can elicit immune responses but concerns about cardiovascular adverse reactions have been raised. Vaccines can increase Spike protein synthesis and immune responses, with genetic and immunological factors possibly impacting reactions.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2021)

Article Multidisciplinary Sciences

Systemic and mucosal immune profiling in asymptomatic and symptomatic SARS-CoV-2-infected individuals reveal unlinked immune signatures

Supriya Ravichandran et al.

Summary: Mucosal immunity plays a key role in preventing the spread of the SARS-CoV-2 virus to the lungs, with independent evolution of antibody responses in mucosal sites. Asymptomatic adults showed significantly higher antibody affinity against the SARS-CoV-2 prefusion spike compared to symptomatic COVID-19 patients. The cytokine/chemokine responses in nasal washes were more robust than in serum, highlighting the importance of evaluating mucosal immune responses for better therapeutics and vaccines against SARS-CoV-2.

SCIENCE ADVANCES (2021)

Article Medicine, General & Internal

Release of infectious virus and cytokines in nasopharyngeal swabs from individuals infected with non-alpha or alpha SARS-CoV-2 variants: an observational retrospective study

Blandine Monel et al.

Summary: The study found that the dynamics of shedding and immune responses of the SARS-CoV-2 alpha variant in the nasal mucosa are still poorly understood. Infectious virus can persist up to 14 days, but majority of individuals can carry infectious virus within two days of symptom onset, with this proportion decreasing over time. The presence of antibodies and cytokines can significantly affect viral load and viral decay.

EBIOMEDICINE (2021)

Article Chemistry, Multidisciplinary

Identification of SARS-CoV-2 Proteins from Nasopharyngeal Swabs Probed by Multiple Reaction Monitoring Tandem Mass Spectrometry

Gabriella Pinto et al.

Summary: Numerous RT-PCR tests have become the gold standard for detecting SARS-CoV-2 infections worldwide over the past year, but shortages of key reagents and unreliable test reliability have led to the search for alternative methods. Authors have developed LC-MS/MS-based methods to detect specific proteins of COVID-19, providing insights for the development of new clinical diagnostics.

ACS OMEGA (2021)

Article Immunology

Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infection

Nikaia Smith et al.

Summary: This study conducted a paired analysis of nasopharyngeal and systemic immune responses in COVID-19 patients, revealing distinct compartmentalization of immunity and shifts in the microbiome.

NATURE IMMUNOLOGY (2021)

Article Microbiology

Oral Microbiome Dysbiosis Is Associated With Symptoms Severity and Local Immune/Inflammatory Response in COVID-19 Patients: A Cross-Sectional Study

Irene Soffritti et al.

Summary: The study revealed that oral dysbiosis in COVID-19 patients is associated with symptom severity and increased local inflammation, while a decreased mucosal immune response was also observed. The characteristics of the HOM may play a significant role in defining individual susceptibility to SARS-CoV-2 infection.

FRONTIERS IN MICROBIOLOGY (2021)

Article Microbiology

Cytokine-Induced Modulation of SARS-CoV2 Receptor Expression in Primary Human Nasal Epithelial Cells

Mahnaz Ramezanpour et al.

Summary: The study found that ACE2 and TMPRSS2 expression in nasal epithelial cells of patients with chronic rhinosinusitis with nasal polyps was lower than in the control group, and was further downregulated after exposure to Th2 cytokines. This suggests that patients may have an immune dysregulated state, altering susceptibility to SARS-CoV-2 infection and transmission.

PATHOGENS (2021)

Article Medicine, General & Internal

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang et al.

LANCET (2020)

Review Immunology

SARS-CoV-2 COVID-19 susceptibility and lung inflammatory storm by smoking and vaping

Gagandeep Kaur et al.

JOURNAL OF INFLAMMATION-LONDON (2020)

Article Biochemical Research Methods

Proteotyping SARS-CoV-2 Virus from Nasopharyngeal Swabs: A Proof-of-Concept Focused on a 3 Min Mass Spectrometry Window

Duarte Gouveia et al.

JOURNAL OF PROTEOME RESEARCH (2020)

Article Biochemistry & Molecular Biology

A Quantitative Proteome Map of the Human Body

Lihua Jiang et al.

Article Respiratory System

Biological markers in nasal secretions

H Riechelmann et al.

EUROPEAN RESPIRATORY JOURNAL (2003)